Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024 · Blood Cancer Journal · 19 citations
https://doi.org/10.1038/s41408-024-01096-6
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
183
Citations
8
h-index
6
i10-index
Giuseppe Bertuglia is an academic researcher from Azienda Ospedaliera Citta' della Salute e della Scienza di Torino. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Peptidase Inhibition and Analysis. The author has an h-index of 8, co-authored 26 publications.
ORCID: 0009-0009-3785-9824https://doi.org/10.1038/s41408-024-01096-6
https://doi.org/10.1002/hon.70042
Click to start Chat